# Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes

> **NCT01326533** · PHASE4 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 32 (actual)

## Conditions studied

- Pre-diabetes

## Interventions

- **DRUG:** hydroxychloroquine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01326533
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-03
- **Final completion:** 2014-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01326533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01326533, "Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01326533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*